NEWS/PRESS RELEASES
-
-
-
November 16, 2023
July 7, 2023
March 10, 2023
February 2, 2023
Latitude Pharmaceuticals Licenses Novel Formulation of Antibiotic to AFT Pharmaceuticals
January 3, 2023
-
-
-
October 30, 2020
September 25, 2020
May 06, 2020
LATITUDE Pharmaceuticals Develops an SC/IM Injectable Remdesivir Formulation
-
-
Sep 20, 2016
Mar 03, 2016
LATITUDE Pharmaceuticals’ Nano-E and PG Depot Featured in March 2016 Issue of Drug Development & Delivery
Jan 11, 2016
LATITUDE Announces New Chinese Patent Granted to Nanoemulsion Composition Containing Vitamin K
-
Dec 01, 2015
LATITUDE Hires Senior Director of Business Development
Nov 09, 2015
LATITUDE Announces Recent Chinese Patent granted to PG Depot
Sep 20, 2015
Cidara Therapeutics Presents Poster on Novel Echinocandin CD101 Gel Formulation by LATITUDE at ICAAC/ICC 2015
-
-
Apr 03, 2012
LATITUDE Pharmaceuticals, Inc. Develops a Stable Liquid Glucagon Formulation
-
Apr 14, 2010
LATITUDE Pharmaceuticals Initiates Four Additional Collaboration Studies For Its PG Depot
-
Sep 15, 2009
Nano-E Antibacterial Emulsion Poster 49th ICAAC Annual Meeting
July 16, 2009
LATITUDE Signs Two More Collaboration Studies for PG Depot
May 12, 2009
Nanoemulsions are a Superior Approach to Formulating Insoluble IV Drugs
May 07, 2009
ADVENTRX Announces Results form ANX-514 Bioequivalence Trial
-
May 16, 2008
ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
May 10, 2008
Novalar Receives FDA Approval For OraVerse